NuVasive to Sponsor and Participate at Society for Minimally Invasive Spine Surgery (SMISS) Annual Forum '22
NuVasive, Inc. (NASDAQ: NUVA) continues its commitment to the Society for Minimally Invasive Spine Surgery (SMISS) by sponsoring and attending the SMISS Annual Forum '22 in Las Vegas from September 29 to October 1, 2022. CEO Chris Barry emphasized the importance of research and education in advancing less invasive surgery, highlighting the company's X360 portfolio and Pulse technology. Attendees can engage with leadership and witness live demonstrations at booth #201/203. The event will also feature the Pioneer in Lateral Access Award during the SOLAS session on September 29.
- Continued sponsorship and participation in the SMISS Annual Forum indicates strong industry relationships.
- Showcasing X360 portfolio and Pulse technology could enhance brand visibility and attract new clients.
- Dependence on industry events for visibility raises concerns about long-term marketing strategies.
SAN DIEGO, Sept. 26, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will continue its partnership with the Society for Minimally Invasive Spine Surgery (SMISS) as a sponsor and will attend the SMISS Annual Forum '22 held September 29 to October 1, 2022 in Las Vegas.
"SMISS and NuVasive share a common belief in the importance of research and education to advance less invasive surgery," said Chris Barry, chief executive officer at NuVasive. "With multiple approaches to enable patient-specific, optimized surgical outcomes, it is important to select the right procedure, create a patient-specific surgical plan, and utilize enabling technologies for more intelligent surgery. We look forward to showcasing our clinically backed X360 portfolio, enabled by Pulse®, at SMISS."
Visit booth #201/203 for live demonstrations of Pulse and conversations with NuVasive leadership around X360 and thoracolumbar posterior procedural solutions. NuVasive will name the Pioneer in Lateral Access Award recipient during the SOLAS session on Thursday, September 29.
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives. The Company's less-invasive, procedurally integrated surgical solutions are designed to deliver reproducible and clinically proven outcomes. The Company's comprehensive procedural portfolio includes surgical access instruments, spinal implants, fixation systems, biologics, software for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative neuromonitoring technology and service offerings. With more than
Forward-Looking Statements
NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons and hospitals, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive's products, the Company's ability to adequately manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nuvasive-to-sponsor-and-participate-at-society-for-minimally-invasive-spine-surgery-smiss-annual-forum-22-301632736.html
SOURCE NuVasive, Inc.
FAQ
What is NuVasive's role in the SMISS Annual Forum '22?
When is the SMISS Annual Forum '22 taking place?
Where will NuVasive be located during the SMISS Annual Forum '22?
What is the significance of the Pioneer in Lateral Access Award?
How does NuVasive aim to advance spine surgery?
